Calliditas Therapeutics AB - ADR logo

CALT

Calliditas Therapeutics AB - ADR

$17.73

Earnings Summary

Revenue
$49.73Mn
Net Profits
$-207.05Mn
Net Profit Margins
-416.31%

Highlights

Revenue:

Calliditas Therapeutics AB - ADR’s revenue jumped +Inf% since last year same period to $49.73Mn in the Q1 2022. On a quarterly growth basis, Calliditas Therapeutics AB - ADR has generated 59.51% jump in its revenue since last 3-months.

Net Profits:

Calliditas Therapeutics AB - ADR’s net profit fell -65.04% since last year same period to $-207.05Mn in the Q1 2022. On a quarterly growth basis, Calliditas Therapeutics AB - ADR has generated 5.53% jump in its net profits since last 3-months.

Net Profit Margins:

Calliditas Therapeutics AB - ADR’s net profit margin jumped NaN% since last year same period to -416.31% in the Q1 2022. On a quarterly growth basis, Calliditas Therapeutics AB - ADR has generated 40.77% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Calliditas Therapeutics AB - ADR post its latest quarter earnings

EPS Estimate Current Quarter
-1.02
EPS Estimate Current Year
-1.02

Highlights

EPS Estimate Current Quarter:

Calliditas Therapeutics AB - ADR’s earning per share (EPS) estimates for the current quarter stand at -1.02 - a 0% jump from last quarter’s estimates.

EPS Estimate Current Year:

Calliditas Therapeutics AB - ADR’s earning per share (EPS) estimates for the current year stand at -1.02.

Key Ratios

Key ratios of the Calliditas Therapeutics AB - ADR post its Q2 2022 earnings

Earning Per Share (EPS)
-0.84

Highlights

Earning Per Share (EPS):

Calliditas Therapeutics AB - ADR’s earning per share (EPS) fell -10.53% since last year same period to -0.84 in the Q2 2022. This indicates that the Calliditas Therapeutics AB - ADR has generated -10.53% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-25
-1.02
-0.84
17.65%
2022-03-31
-1.02
-0.84
17.65%

Company Information

Organisation
Calliditas Therapeutics AB - ADR
Headquarters
Stockholm, Stockholm, Sweden
Employees
46
Industry
Health Technology